Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child (IRON KID)

  • End date
    Jun 30, 2024
  • participants needed
  • sponsor
    University Hospital, Montpellier
Updated on 26 February 2022


Oral iron is commonly used in conjunction with EPO preoperatively for hemorrhagic surgeries in children and especially in the surgery of craniosynostosis. The bioavailability of oral iron is low and compliance with treatment is inconsistent. The aim of this study is to evaluate whether the use of ferric carboxymaltose by injection, which has a much better bioavailability, would make it possible to increase the preoperative hemoglobin level more effectively and thus reduce the risk of perioperative blood transfusion .


Prospective study, randomized in two parallel groups (martial treatment versus venous injection) and stratified by center (Montpellier, Nice, Angers).

The number of subjects required is 100 patients, or 50 per group.

Condition Craniosynostosis
Treatment Ferrous fumarate, Ferrous fumarate or ferrostrane
Clinical Study IdentifierNCT03231085
SponsorUniversity Hospital, Montpellier
Last Modified on26 February 2022


Yes No Not Sure

Inclusion Criteria

Craniosynostosis Surgery
Age: between 4 and 24 months inclusive
Weight: less than 12kg
Hemoglobin: 10 g / dl ≤ Hb 14 ≤ g / dl
Affiliated patients or beneficiaries of a Social Security scheme
Signature of the consent of the patient's parents

Exclusion Criteria

Generalized infection
Time for consultation of anesthesia with respect to the date of surgery greater than 5 weeks or less than 22 days
Initial biological assessment dating more than 3 months before the consultation of anesthesia
Parents do not understand French
BMI greater than 20 kg.m-2
Contraindications to EPO
Contraindications to ferric carboxymaltose and to ferrous fumarate
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note